Product Information
FENOFIBRATE 50 MG CAPSULE is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $2.5681 per EA under NDC 62559046090. Its NADAC has been published 189 times since May 18, 2016.
FDA first approved this application on Jan 11, 2006.
The High Outlier badge above means this manufacturer's average price in the fenofibrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559046090
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
FENOFIBRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021612FDA Approved
1/11/2006
On Market Since
4/13/2016
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 50 MG CAPSULE has been published 189 times since May 18, 2016, and over the history we have for it it has risen 25.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.5681 per EA |
|---|---|
| All-time high | $2.6049 (Jun 10, 2026) |
| All-time low | $2.0529 (May 18, 2016) |
| 52-week high | $2.6049 |
| 52-week low | $2.5171 |
| Median price | $2.4580 |
| Average price | $2.3927 |
| Largest weekly change | +12.4% (Aug 17, 2016) |
| Weeks tracked | 189 |
| Tracking since | May 18, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fenofibrate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FENOFIBRATE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 50 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $2.5681 per EA (NDC 62559046090), effective Aug 19, 2026.
How has the price of FENOFIBRATE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 50 MG CAPSULE has risen 25.1%. It has been tracked across 189 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 50 MG CAPSULE?
Since May 18, 2016, the NADAC for FENOFIBRATE 50 MG CAPSULE has ranged from a low of $2.0529 (May 18, 2016) to a high of $2.6049 (Jun 10, 2026), with a median of $2.4580 per EA.
Are there cheaper alternatives to FENOFIBRATE 50 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of FENOFIBRATE 50 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FENOFIBRATE 50 MG CAPSULE?
FENOFIBRATE 50 MG CAPSULE (NDC 62559046090) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.